Article Versions Notes

Hoyer H, Scheungraber C, Mehlhorn G, Hagemann I, Scherbring S, Wölber L, Petzold A, Wunsch K, Schmitz M, Hampl M, et al. Accuracy of GynTect^® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study. Cancers. 2024; 16(17):3022. https://doi.org/10.3390/cancers16173022

Hoyer, Heike, Cornelia Scheungraber, Grit Mehlhorn, Ingke Hagemann, Sarah Scherbring, Linn Wölber, Annett Petzold, Kristina Wunsch, Martina Schmitz, Monika Hampl, and et al. 2024. "Accuracy of GynTect^® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study" Cancers 16, no. 17: 3022. https://doi.org/10.3390/cancers16173022

Hoyer, H., Scheungraber, C., Mehlhorn, G., Hagemann, I., Scherbring, S., Wölber, L., Petzold, A., Wunsch, K., Schmitz, M., Hampl, M., Böhmer, G., Hillemanns, P., Runnebaum, I. B., & Dürst, M. (2024). Accuracy of GynTect^® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study. Cancers, 16(17), 3022. https://doi.org/10.3390/cancers16173022